ECCO 13 - the European Cancer Conference (ESTRO 24)

Konferenční abstrakta:

Konferenční abstrakta jsou přístupná na konferenčních stránkách ECCO.

Aktivní účast z České republiky na ECCO 2005:

Na kongresu ECCO bylo v letošním roce publikováno 16 příspěvků účastníky, kteří přijeli z České republiky:

• Seznam prezentací a publikací ve sborníku kongresu účastníky v České republiky najdete na konferenčních stránkách. Z názvů vedou odkazy na abstrakta sdělení.

Abstract 1119	M. Baumann12, T. Herrmann12, R. Koch13, B. Wahlers4, L. Kepka5, G. Marschke6, D. Feltl7, R. Fietkau8, V. Budach9, J. Dunst10 Continuous hyperfractionated accelerated radiotherapy - weekend less (CHARTWEL) versus conventionally fractionated (CF) radiotherapy in non-small-cell lung cancer (NSCLC): first results of a phase III randomised multicentre trial (ARO 971) European Journal of Cancer Supplements Volume 3, No. 2, October 2005, Page 322
Abstract 1133	J.M. Sánchez1, K. Osterlind2, P. Zatloukal3, J. Hamm4, C.P. Belani5, E. Kim6, E. Felip7, M. Berton8, I. Sklenar8, A. Johri9 Phase I/II dose-escalation trial of patupilone every 3 weeks in patients with non-small cell lung cancer European Journal of Cancer Supplements Volume 3, No. 2, October 2005, Page 327
Abstract 1194	G. Simonova, R. Liscak, J. Novotny Jr. Hospital Na Homolce, Stereotactic Radioneurosurgery, Prague 5, Czech Republic Uveal melanomas treated BZ gamma knife Citation: European Journal of Cancer Supplements Volume 3, No. 2, October 2005, Page 345
Abstract 1231	K. Zitterbart1, J. Kadlecova2, I. Zavrelova3, J. Sterba1 1University Hospital Brno, Department of Paediatric Oncology, Brno, Czech Republic 2University Hospital Brno, Department of Medical Genetics, Brno, Czech Republic 3University Hospital Brno, Department of Pathology, Brno, Czech Republic TP73 expression in medulloblastoma European Journal of Cancer Supplements Volume 3, No. 2, October 2005, Page 355
Abstract 1245	M. Nekolna1, E. Kabickova1, R. Kodet2, J. Stary1, E. Drahokoupilova1 1Faculty Hospital Motol, Dept. of Paediatric Hematology and Oncology, Prague, Czech Republic 2Faculty Hospital Motol, Dept. of Pathology and Molecular Biology, Prague, Czech Republic Experience with treatment of lymphocyte predominance Hodgkin's disease in children European Journal of Cancer Supplements Volume 3, No. 2, October 2005, Page 359
Abstract 1414	P. Vitek1, O. Taltynov2, P. Hozák2, J. Rosina3, J. Zamecnik1 1Institute of Radiation Oncology, Univ. Hospital Na Bulovce, Prague, Czech Republic 2Institute of Experimental Medicine, Czech Academy of Science, Prague, Czech Republic 3Institute of Biophysics, 3rd Medical Faculty Charles University, Prague, Czech Republic Induction of fluoropyrimidine metabolizing enzymes after an exposure of a cancer cell to an ionizing radiation - a concept supporting continuous schedules of chemoradiotherapy European Journal of Cancer Supplements Volume 3, No. 2, October 2005, Page 409
Abstract 1521	H. Vorlickova Masaryk Memorial Cancer Institute, Brno, Czech Republic Cancer care management: implication for oncology nurses European Journal of Cancer Supplements Volume 3, No. 2, October 2005, Page 443
Abstract 195	Z. Tuhackova, M. Vojtechova, D. Kucerova, A. Bukovska, E. Sloncova Institute of Molecular Genetics, Academy of Science, Dept. of Intracellular Communications, Prague, Czech Republic Oncogenesis of vSrc-transformed cells is associated with upregulation of mTOR signalling pathway European Journal of Cancer Supplements Volume 3, No. 2, October 2005, Page 55
Abstract 282	J. Prokopcova, M. Janatova, P. Pohlreich, B. Matous 1st Faculty of Medicine, Charles University, Prague, Institute of Biochemistry and Exp. Oncology, Prague, Czech Republic The analysis of ATM mutations in high-risk breast cancer patients Citation: European Journal of Cancer Supplements Volume 3, No. 2, October 2005, Page 79
Abstract 288	M. Janatova, P. Pohlreich, J. Prokopcova, B. Matous First Faculty of Medicine, Charles University, Institute of Biochemistry and Exp. Oncology, Prague, Czech Republic Inactivation of the BRCA1, BRCA2- and p53-genes in sporadic breast carcinomas Inactivation of the BRCA1, BRCA2- and p53-genes in sporadic breast carcinomas European Journal of Cancer Supplements Volume 3, No. 2, October 2005, Page 81
Abstract 305	G. Turashvili1, G. Burkadze2, Z. Kolar1 1Palacky University, Institute of Pathology, Olomouc, Czech Republic 2Tbilisi State Medical University, Pathology, Tbilisi, Georgia Expression pattern of E cadherin in invasive ductal breast carcinoma European Journal of Cancer Supplements Volume 3, No. 2, October 2005, Page 86
Abstract 316	P. Pohlreich1, J. Stribrna1, M. Zikan1, Z. Kleibl1, B. Matous1, J. Novotny2 1First Faculty of Medicine, Charles University, Dept. of Biochemistry and Experimental Oncology, Prague, Czech Republic 2First Faculty of Medicine, Charles University, Dept.of Oncology, Prague, Czech Republic Analysis of BRCA1 and BRCA2 mutations in high-risk patients from the Prague-area European Journal of Cancer Supplements Volume 3, No. 2, October 2005, Page 89
Abstract 320	M. Zikan12, P. Pohlreich1, J. Novotny3, Z. Kleibl1, M. Janatova1 1Charles University in Praque, First Faculty of Med, Institute of Biochemistry and Experimental Oncolog, Prague, Czech Republic 2Charles University in Prague, First Faculty of Medicine, and General Faculty Hos, Clinic of Obstetrics and Gynecology, Prague, Czech Republic 3Charles University in Prague, First Faculty of Medicine, and General Faculty Hos, Clinic of Oncology, Prague, Czech Republic High frequency of population-specific mutations of BRCA genes among breast cancer patients in the Czech Republic European Journal of Cancer Supplements Volume 3, No. 2, October 2005, Page 90
Abstract 663	R. Lohynska, J. Prausova, E. Kubala, B. Malinova, K. Kubackova University Hospital Motol, Radiotherapy and Oncology, Prague, Czech Republic Prognostic index for adjuvant treatment in locally advanced rectal cancer after preoperative chemoradiotherapy and radiotherapy European Journal of Cancer Supplements Volume 3, No. 2, October 2005, Page 188
Abstract 693	J. Dvorak1, R. Voboril2, P. Hladik2, P. Vesely1, B. Melichar1, J. Petera1, Z. Zoul1, M. Vosmik1, P. Jandik2, J. Mergancova2 1Charles University Hospital, Oncology and Radiotherapy, Hradec Kralove, Czech Republic 2Charles University Hospital, Surgery, Hradec Kralove, Czech Republic Preoperative neoadjuvant radiochemotherapy for rectal adenocarcinoma European Journal of Cancer Supplements Volume 3, No. 2, October 2005, Page 196
Abstract 709	R. Sefr1, I. Kocakova2, I. Penka1, P. Slampa3 1Masaryk Memorial Cancer Center, Surgery, Brno, Czech Republic 2Masaryk Memorial Cancer Center, Medical Oncology 3Memorial Cancer Center, Radiation Oncology, Brno, Czech Republic Preoperative radiotherapy and oral capecitabine improve surgical results in patients with locally advanced mid-lower rectal cancer European Journal of Cancer Supplements Volume 3, No. 2, October 2005, Page 201

Pozvánka na akci

Termíny

Podání abstrakt: 25. května 2005
Časná regsitrace: 18. dubna 2005
Pozdní registrace: 16. září 2005
Závěr registrace před kongresem (dále na místě): 14. října 2005
Rezervace ubytování: 16. září 2005

Registrace v místě konání:

registrace před kongresem a online registrace byla již uzavřena, můžete se registrovat v místě konání konference: Hall Maillot - sekce B od neděle 30.10.

Abstrakta

Online podání abstraktu na stránkách ECCO bylo uzavřeno 25. května 2005. Odborný program byl uveřejněn na konferenčních stránkách.
Program můžete prohledávat, nebo si ho stáhnout a vytisknout v pdf formátu.
Předběžný program, registrace na konferenci, pokyny k tvorbě a zasílání abstraktů a registrace ubytování je již k dispozici 3.11.2004

Kontakt: ECCO13@fecs.be

Web: www.fecs.be/emc.asp?pageId=10&Type=P